All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • DIAG723Phase 21 trial

    Diagonal Therapeutics, Inc. · Hereditary Hemorrhagic Telangiectasia, Pulmonary Arterial Hypertension

  • DII235Phase 21 trial

    Novartis · Lipoprotein Disorder

  • DiranersenISIS 814907, BIIB080Phase 21 trial

    Biogen · Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia

  • DISC-3405Phase 21 trial

    Disc Medicine, Inc · Polycythemia Vera (PV)

  • Dispensing CodivirPhase 21 trial

    Code Pharma · HIV, HIV Infection

  • DJI136Phase 21 trial

    Novartis · Extensive-stage Small Cell Lung Cancer (ES-SCLC)

  • DKN-01LY2812176Phase 21 trial

    Leap Therapeutics, Inc. · Colorectal Cancer, Colorectal Adenocarcinoma, Colo-rectal Cancer

  • DL001ZF2G22B, F2H23HPhase 21 trial

    GSK · Influenza, Human

  • DL001Z-NHF2H23D, F2H23BPhase 21 trial

    GSK · Influenza, Human

  • DM-101PXPhase 21 trial

    Desentum Oy · Birch Pollen Allergy

  • DM002Phase 21 trial

    Xadcera Biopharmaceutical (Suzhou) Co., Ltd. · Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

  • DM005Phase 21 trial

    Doma Biopharmaceutical(Suzhou)Co., Ltd. · Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of Head and Neck, Solid Carcinoma

  • DNL126Phase 21 trial

    Denali Therapeutics Inc. · Mucopolysaccharidosis Type IIIA

  • DNL593Phase 21 trial

    Denali Therapeutics Inc. · Frontotemporal Dementia

  • DNL952Phase 21 trial

    Denali Therapeutics Inc. · Late-onset Pompe Disease

  • DNV001Phase 21 trial

    Hangzhou Dinovate Biotech Co., Ltd · Primary Hypercholesterolemia

  • DocetetaxelPhase 21 trial

    Merck & Co. · Carcinoma, Non-Small-Cell Lung

  • DONQ52Phase 21 trial

    Chugai Pharmaceutical · Celiac Disease

  • DR30206Phase 21 trial

    Zhejiang Doer Biologics Co., Ltd. · Gastrointestinal Cancer

  • DS-1103aPhase 21 trial

    Daiichi Sankyo · Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer

  • DS-7011aPhase 21 trial

    Daiichi Sankyo · Systemic Lupus Erythematosus

  • DS3790aPhase 21 trial

    Daiichi Sankyo · Hematological Malignancies, B-cell Non-Hodgkin Lymphoma

  • DT-168Phase 21 trial

    Design Therapeutics, Inc. · Fuchs Endothelial Corneal Dystrophy, Fuchs

  • DT-216P2Phase 21 trial

    Design Therapeutics, Inc. · Friedreich Ataxia

  • DT-7012Phase 21 trial

    Domain Therapeutics Australia Pty Ltd · Advanced Solid Tumors

  • DusquetideSGX945, SGX942Phase 21 trial

    Soligenix · Behçet Disease

  • DWN12088DWN12088 XmgPhase 21 trial

    Daewoong Pharmaceutical Co. LTD. · Idiopathic Pulmonary Fibrosis

  • DX243Phase 21 trial

    Dendrogenix · Age-related Hearing Loss

  • DXC006Phase 21 trial

    Hangzhou DAC Biotechnology Co., Ltd. · Small Cell Lung Cancer

  • DYP688Phase 21 trial

    Novartis · Metastatic Uveal Melanoma

  • E2086Phase 21 trial

    Eisai · Narcolepsy

  • E2814Phase 21 trial

    Eisai · Alzheimer's Disease

  • E6742Phase 21 trial

    Eisai · Systemic Lupus Erythematosus

  • E7090Phase 21 trial

    Eisai · Cholangiocarcinoma

  • E7386Phase 21 trial

    Eisai · Endometrial Neoplasms, Neoplasms, Carcinoma, Hepatocellular

  • E7389-LFPhase 21 trial

    Eisai · Solid Neoplasms

  • EB-701CA9-NKPhase 21 trial

    Beijing Biotech · Advanced or Metastatic Clear Cell Renal Cell Carcinoma

  • EB06Phase 21 trial

    Edesa Biotech Inc. · Non-Segmental Vitiligo (NSV)

  • EB103Phase 21 trial

    Estrella Immunopharma, Inc. · B-Cell Non-Hodgkin's Lymphoma (NHL), Lymphoma, Non-Hodgkins, Lymphomas Non-Hodgkin's B-Cell

  • EC5026Phase 21 trial

    EicOsis Human Health Inc. · Parkinson's Disease (PD)

  • ECC0509Phase 21 trial

    Eccogene · Metabolic Dysfunction-associated Steatohepatitis

  • ECI830Phase 21 trial

    Novartis · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer

  • EDG-15400Phase 21 trial

    Edgewise Therapeutics, Inc. · Heart Failure With Preserved Ejection Fraction

  • EDG-7500Phase 21 trial

    Edgewise Therapeutics, Inc. · Hypertrophic Cardiomyopathy

  • EDI048Phase 21 trial

    Novartis · Cryptosporidiosis

  • EDIT-401Phase 21 trial

    Editas Medicine, Inc. · Heterozygous Familial Hypercholesterolemia (HeFH)

  • EDP-938Phase 21 trial

    Enanta Pharmaceuticals, Inc · RSV Infection

  • EF-009Phase 21 trial

    Everfront Biotech Co., Ltd. · Pancreatic Cancer

  • EfesovirFS-1Phase 21 trial

    Scientific Center for Anti-infectious Drugs, Kazakhstan · Covid19

  • EfineptakinNT-I7, rhIL-7-hyFcPhase 21 trial

    NeoImmuneTech · Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer

NewerPage 51 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.